Syed O Hasan
Examiner (ID: 9396, Phone: (571)272-0990 , Office: P/3747 )
Most Active Art Unit | 3747 |
Art Unit(s) | 3783, 3747 |
Total Applications | 907 |
Issued Applications | 710 |
Pending Applications | 53 |
Abandoned Applications | 143 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16512912
[patent_doc_number] => 20200392170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => COT MODULATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/994889
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16994889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/994889 | Cot modulators and methods of use thereof | Aug 16, 2020 | Issued |
Array
(
[id] => 16582775
[patent_doc_number] => 20210017177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/990827
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 147896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 809
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990827
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990827 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | Aug 10, 2020 | Abandoned |
Array
(
[id] => 19060103
[patent_doc_number] => 11939311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Acid-labile surfactants
[patent_app_type] => utility
[patent_app_number] => 16/986682
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13674
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986682
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986682 | Acid-labile surfactants | Aug 5, 2020 | Issued |
Array
(
[id] => 16598002
[patent_doc_number] => 20210024533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => THERMOLYSIS-MEDIATED PROCESS FOR MANUFACTURING CHROMENES INTENDED FOR THE PREPARATION OF THERMOSETTING RESINS
[patent_app_type] => utility
[patent_app_number] => 16/936915
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936915 | Thermolysis-mediated process for manufacturing chromenes intended for the preparation of thermosetting resins | Jul 22, 2020 | Issued |
Array
(
[id] => 16557105
[patent_doc_number] => 20210002253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/936257
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936257
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936257 | Aryl cyclopropyl-amino-isoquinolinyl amide compounds | Jul 21, 2020 | Issued |
Array
(
[id] => 16421874
[patent_doc_number] => 20200347072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => Tricyclic Compounds Useful to Treat Orthomyxovirus Infections
[patent_app_type] => utility
[patent_app_number] => 16/933000
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933000 | Tricyclic compounds useful to treat orthomyxovirus infections | Jul 19, 2020 | Issued |
Array
(
[id] => 17776543
[patent_doc_number] => 20220242892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => 1,2-BIS(DIPHENYLPHOSPHINOALKYLAMIDO)-1,2-DISUBSTITUTED ETHANE, AND ITS SYNTHESIS AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/629075
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17629075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/629075 | 1,2-BIS(DIPHENYLPHOSPHINOALKYLAMIDO)-1,2-DISUBSTITUTED ETHANE, AND ITS SYNTHESIS AND APPLICATION | Jul 7, 2020 | Pending |
Array
(
[id] => 18413085
[patent_doc_number] => 11667617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Catalyst recycle methods
[patent_app_type] => utility
[patent_app_number] => 16/919763
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16476
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919763 | Catalyst recycle methods | Jul 1, 2020 | Issued |
Array
(
[id] => 16525138
[patent_doc_number] => 20200399218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES
[patent_app_type] => utility
[patent_app_number] => 16/904370
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16904370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/904370 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND ARTICLES OF MANUFACTURE FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES | Jun 16, 2020 | Pending |
Array
(
[id] => 18836765
[patent_doc_number] => 11844822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Solid formulation and method for preventing or reducing coloration thereof
[patent_app_type] => utility
[patent_app_number] => 16/901800
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13621
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16901800
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/901800 | Solid formulation and method for preventing or reducing coloration thereof | Jun 14, 2020 | Issued |
Array
(
[id] => 16673091
[patent_doc_number] => 20210061854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => NOVEL POLYMORPHIC FORMS OF CYCLO (-HIS-PRO)
[patent_app_type] => utility
[patent_app_number] => 16/901676
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16901676
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/901676 | Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease | Jun 14, 2020 | Issued |
Array
(
[id] => 17451803
[patent_doc_number] => 11266638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Choline salt forms of an HIV capsid inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/892377
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 25918
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892377 | Choline salt forms of an HIV capsid inhibitor | Jun 3, 2020 | Issued |
Array
(
[id] => 17539812
[patent_doc_number] => 11304916
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Methods and compositions for the treatment of Shiga Toxicosis
[patent_app_type] => utility
[patent_app_number] => 16/890710
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 68
[patent_no_of_words] => 11863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890710 | Methods and compositions for the treatment of Shiga Toxicosis | Jun 1, 2020 | Issued |
Array
(
[id] => 17490411
[patent_doc_number] => 11279700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Ion channel modulators
[patent_app_type] => utility
[patent_app_number] => 16/887897
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887897
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887897 | Ion channel modulators | May 28, 2020 | Issued |
Array
(
[id] => 16776455
[patent_doc_number] => 20210113532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/885766
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16885766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/885766 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | May 27, 2020 | Abandoned |
Array
(
[id] => 16504713
[patent_doc_number] => 20200383969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => RIMEGEPANT FOR CGRP RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/884196
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884196 | Rimegepant for CGRP related disorders | May 26, 2020 | Issued |
Array
(
[id] => 16468142
[patent_doc_number] => 20200369679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => PROTEIN-TARGETING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/882750
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16882750
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/882750 | Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications | May 25, 2020 | Issued |
Array
(
[id] => 18128833
[patent_doc_number] => 11555032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Isoxazole derivatives as FXR agonists and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/871551
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26724
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 352
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871551 | Isoxazole derivatives as FXR agonists and methods of use thereof | May 10, 2020 | Issued |
Array
(
[id] => 17749516
[patent_doc_number] => 20220227720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/609135
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 489
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609135 | DHODH INHIBITORS AND THEIR USE AS ANTIVIRAL AGENTS | May 5, 2020 | Abandoned |
Array
(
[id] => 17859746
[patent_doc_number] => 11440891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-13
[patent_title] => Formation of N-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine
[patent_app_type] => utility
[patent_app_number] => 16/866056
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 3578
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866056
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866056 | Formation of N-protected 3,6-bis-(4-aminoalkyl)-2,5,diketopiperazine | May 3, 2020 | Issued |